CD3 Results

I got a call yesterday with the results of my bloodwork from CD3 (March 6).

LH = 1.4 (apparently less than 7 is very good)
FSH = 4.8 (apparently less than 6 is excellent)
Estradiol = 232 (or 63.2 for you Americans; within normal but above 75 is VERY high)

If your LH is greater than your FSH it could be an indicator of PCOS. So these numbers seem to indicate no PCOS, at least to me.

********
Edited to add...
I found the following information on a website from a Chicago clinic:

"A blood estradiol level on day 3 (we do it on any day between days 2 and 4) of the menstrual cycle is a way to potentially discover some of those women with a normal day 3 FSH that may in fact have decreased egg quantity and quality. What we would like to see on day three is a low FSH level in conjunction with a low estradiol level. If the FSH is normal but the estradiol level is elevated, the elevated estradiol may be artificially suppressing the FSH level in to the normal range.

The idea of using day 3 estradiol levels as an adjunct in evaluating egg quantity and quality is relatively new. Clearly defined cutoff values for normal and abnormal are not well defined and are also lab-dependent. I like to see the day 3 estradiol less than about 80. In our experience, levels of 80-100 are borderline, and over 100 is abnormal. We like to repeat any borderline results in another cycle.

There is not much data that suggests that an elevated day 3 estradiol is a problem in itself. The problem is more so that it is potentially "masking" the detection of the poor ovarian reserve by suppressing an FSH level that would otherwise be elevated."


Knowing that in US terms, the E2 level is 63.2, that would seem "normal" to me. But am I wrong? Argh.

********

Any informed people care to weigh in on this one?

CD23 results to follow sometime next week. The trick is to get my CD23 results and analysis before CD3 arrives. Otherwise I will have to wait another month to cycle because until I know what the bloodwork says, I'm not spending another cent on cycle meds and donor samples as there may be underlying factors that need to be dealt with first.